Rectal Cancer Clinical Trial
Official title:
Randomized Non-inferiority Trial of Selective Splenic Flexure Mobilization for the Formation of Low Colorectal Anastomosis After Total Mesorectal Excision and D3 Paraaortic Lymph Node Dissection in Low Rectal Cancer.
In the Low Anterior Resection of rectum for cancer, the section level of IMA and the need of
SFM is still debated.
The aim of this study is to explore the different impacts of high and low ligation with
peeling off vascular sheath of inferior mesenteric artery (IMA) in low anterior resection of
the rectum for cancer. This study purpose to demonstrate that low IMA ligation, sparing of
left colic artery (LCA) and selective SFM results in higher anastomotic leakage rate than
high IMA ligation with routine SFM (with the difference of more than 5%).
Although TME is the standard curative operation for rectal cancer patients, who undergo low
anterior resection (LAR) or abdominoperineal resection (APR) with a permanent colostomy, the
strategy to restore the transit between colon and rectum (in case of LAR) is still debated in
literature.
Several studies comparing high-tie with low-tie ligation reported a stage-specific survival
benefit for high-tie, but on the other hand recent studies demonstrated that low-tie, without
splenic flexure mobilization (SFM), decreases the complexity of the laparoscopic procedure
and could reduces the operating time with comparable oncological outcomes.
The method of restorative surgery, after Total Mesorectal Excision (TME), largely depends on
the length of the resected part of the colon, that is related to patient's anatomical
features and the height of vascular ligation performed during the operation.
In attempt to perform a radical paraaortic lymph node dissection the inferior mesenteric
artery (IMA) is usually ligated at its origin and the Arcade of Riolan provides bloody supply
to any distal anastomosis. Unfortunately the Arcade of Riolan is an inconstant finding and
sometimes (26% of cases) is mandatory to mobilize the splenic flexure to ensure a safe and
tension-free anastomosis. SFM is a time-consuming component of LAR, has the additional risk
of iatrogenic splenic injury and is very difficult during a laparoscopic resection.
In 2005 was demonstrated that routine SFM is not always necessary during anterior resection
for rectal cancer.
A recent retrospective analysis by Mouw showed that SFM was associated with wider margins and
a decreased rate of inadequate nodal staging in patients undergoing LAR.
This trial aims to demonstrate that low IMA ligation, sparing of LCA and selective SFM
results in higher anastomotic leakage rate than high IMA ligation with routine SFM (with the
difference of more than 5%). Furthermore this study purpose to evaluate the need to perform
splenic flexure mobilization (SFM) in low ligation group and the, operation time, apical
lymph nodes positive rate and short terms postoperative complication in both groups
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06380101 -
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
|
N/A | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Recruiting |
NCT04323722 -
Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
| Active, not recruiting |
NCT01347697 -
Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer
|
N/A | |
| Recruiting |
NCT04495088 -
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
|
Phase 3 | |
| Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
| Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT03520088 -
PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS
|
N/A | |
| Recruiting |
NCT05556473 -
F-Tryptophan PET/CT in Human Cancers
|
Phase 1 | |
| Recruiting |
NCT04749381 -
The Role of TCM on ERAS of Rectal Cancer Patients
|
Phase 2 | |
| Enrolling by invitation |
NCT05028192 -
Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
|
||
| Recruiting |
NCT03283540 -
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
|
||
| Completed |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A | |
| Recruiting |
NCT05914766 -
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
|
N/A | |
| Recruiting |
NCT04852653 -
A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
|
||
| Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
| Terminated |
NCT02933944 -
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
|
Phase 1 | |
| Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A |